Site Logo
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors & Partners
    • Investment Partners
  • Alzheimer's Products
    • Alzheimer’s Overview
    • Cytox approach - Polygenic Risk Scoring (PRS)
    • genoSCORE™-LAB – Risk assessment in Alzheimer’s disease
    • Sampled Alzheimer's Risk Test
    • genoTOR – mTOR Targeted Drug Development
    • Copy of Sampled Alzheimer's Risk Test
  • Resources
    • Press Releases
    • Articles
    • Newsletters
    • Upcoming Events
    • Posters & Presentations
    • Bibliography
  • Work With Us
    • Genotyping Services Partners
    • Platform Partner
    • Working with Cytox
  • Contact & Subscribe
  •  

enquiries@cytoxgroup.com

Newsletters

Newsletters

100 Clinics Up and Running - Newsletter 10, Sep 2022
New look Alzheimer’s Risk Test - Newsletter 9, Apr 2022
Ordered the Alzheimer’s Risk Test yet? - Newsletter 8, Feb 2022
Alzheimer’s Risk Tests now available - Newsletter 7 Dec 2021
New Alzheimer’s Risk Test to launch in the US & Canada - Newsletter 6 Sept 2021
Cytox welcomes Aduhelm - Newsletter 5 July 2021
Cytox launches genoSCORE-LAB - Newsletter 4 Feb 2021
New Products and Approaches - Newsletter 3 Apr 2020
Cytox at CTAD 2019 - Newsletter 2 Nov 2019
Webinar - Polygenic Risk Score analysis for Alzheimer's disease risk
Cytox at AAIC 2019 - Newsletter 1 Jul 2019

© 2023 Cytox

Disclaimer

Privacy

Terms and Conditions